203 related articles for article (PubMed ID: 11812997)
1. CD94-NKG2A receptors regulate antiviral CD8(+) T cell responses.
Moser JM; Gibbs J; Jensen PE; Lukacher AE
Nat Immunol; 2002 Feb; 3(2):189-95. PubMed ID: 11812997
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
[TBL] [Abstract][Full Text] [Related]
3. The role of TCR stimulation and TGF-beta in controlling the expression of CD94/NKG2A receptors on CD8 T cells.
Gunturi A; Berg RE; Crossley E; Murray S; Forman J
Eur J Immunol; 2005 Mar; 35(3):766-75. PubMed ID: 15714583
[TBL] [Abstract][Full Text] [Related]
4. Tumor viral escape from inhibited T cells.
Welsh RM; Stepp SE; Szomolanyi-Tsuda E; Peacock CD
Nat Immunol; 2002 Feb; 3(2):112-4. PubMed ID: 11812984
[No Abstract] [Full Text] [Related]
5. CD94/NKG2A expression is associated with proliferative potential of CD8 T cells during persistent polyoma virus infection.
Byers AM; Andrews NP; Lukacher AE
J Immunol; 2006 May; 176(10):6121-9. PubMed ID: 16670321
[TBL] [Abstract][Full Text] [Related]
6. Activating CD94:NKG2C and inhibitory CD94:NKG2A receptors are expressed by distinct subsets of committed CD8+ TCR alphabeta lymphocytes.
Arlettaz L; Villard J; de Rham C; Degermann S; Chapuis B; Huard B; Roosnek E
Eur J Immunol; 2004 Dec; 34(12):3456-64. PubMed ID: 15517612
[TBL] [Abstract][Full Text] [Related]
7. Triggering of effector functions on a CD8+ T cell clone upon the aggregation of an activatory CD94/kp39 heterodimer.
Bellón T; Heredia AB; Llano M; Minguela A; Rodriguez A; López-Botet M; Aparicio P
J Immunol; 1999 Apr; 162(7):3996-4002. PubMed ID: 10201920
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E2 induces the expression of functional inhibitory CD94/NKG2A receptors in human CD8+ T lymphocytes by a cAMP-dependent protein kinase A type I pathway.
Zeddou M; Greimers R; de Valensart N; Nayjib B; Tasken K; Boniver J; Moutschen M; Rahmouni S
Biochem Pharmacol; 2005 Sep; 70(5):714-24. PubMed ID: 15978547
[TBL] [Abstract][Full Text] [Related]
9. Persistent expression of CD94/NKG2 receptors by virus-specific CD8 T cells is initiated by TCR-mediated signals.
Wojtasiak M; Jones CM; Sullivan LC; Winterhalter AC; Carbone FR; Brooks AG
Int Immunol; 2004 Sep; 16(9):1333-41. PubMed ID: 15302848
[TBL] [Abstract][Full Text] [Related]
10. Implication for the CD94/NKG2A-Qa-1 system in the generation and function of ocular-induced splenic CD8+ regulatory T cells.
Chattopadhyay S; O'Rourke J; Cone RE
Int Immunol; 2008 Apr; 20(4):509-16. PubMed ID: 18359787
[TBL] [Abstract][Full Text] [Related]
11. Visualization of polyoma virus-specific CD8+ T cells in vivo during infection and tumor rejection.
Lukacher AE; Moser JM; Hadley A; Altman JD
J Immunol; 1999 Sep; 163(6):3369-78. PubMed ID: 10477607
[TBL] [Abstract][Full Text] [Related]
12. The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells.
Gumá M; Busch LK; Salazar-Fontana LI; Bellosillo B; Morte C; García P; López-Botet M
Eur J Immunol; 2005 Jul; 35(7):2071-80. PubMed ID: 15940674
[TBL] [Abstract][Full Text] [Related]
13. Differential induction of CD94 and NKG2 in CD4 helper T cells. A consequence of influenza virus infection and interferon-gamma?
Graham CM; Christensen JR; Thomas DB
Immunology; 2007 Jun; 121(2):238-47. PubMed ID: 17462078
[TBL] [Abstract][Full Text] [Related]
14. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.
Della Chiesa M; Vitale M; Carlomagno S; Ferlazzo G; Moretta L; Moretta A
Eur J Immunol; 2003 Jun; 33(6):1657-66. PubMed ID: 12778484
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of natural killer cell receptors (CD94/NKG2A) on T cells by the stimulation of G-CSF-mobilized peripheral blood mononuclear cells with anti-CD3 monoclonal antibody and cytokines: a study in stem cell donors.
Tanaka J; Toubai T; Miura Y; Tsutsumi Y; Kato N; Umehara S; Toyoshima N; Ohta S; Asaka M; Imamura M
Transplant Proc; 2004 Oct; 36(8):2511-2. PubMed ID: 15561299
[TBL] [Abstract][Full Text] [Related]
16. Expansion of natural killer cell receptor (CD94/NKG2A)-expressing cytolytic CD8 T cells and CD4+CD25+ regulatory T cells from the same cord blood unit.
Tanaka J; Sugita J; Kato N; Toubai T; Ibata M; Shono Y; Ota S; Kondo T; Kobayashi T; Kobayashi M; Asaka M; Imamura M
Exp Hematol; 2007 Oct; 35(10):1562-6. PubMed ID: 17681668
[TBL] [Abstract][Full Text] [Related]
17. The cell biology of the human natural killer cell CD94/NKG2A inhibitory receptor.
Borrego F; Masilamani M; Kabat J; Sanni TB; Coligan JE
Mol Immunol; 2005 Feb; 42(4):485-8. PubMed ID: 15607803
[TBL] [Abstract][Full Text] [Related]
18. CD94/NKG2 expression does not inhibit cytotoxic function of lymphocytic choriomeningitis virus-specific CD8+ T cells.
Miller JD; Peters M; Oran AE; Beresford GW; Harrington L; Boss JM; Altman JD
J Immunol; 2002 Jul; 169(2):693-701. PubMed ID: 12097371
[TBL] [Abstract][Full Text] [Related]
19. Amelioration of acute graft-versus-host disease by NKG2A engagement on donor T cells.
Kawamura H; Yagita H; Nisizawa T; Izumi N; Miyaji C; Vance RE; Raulet DH; Okumura K; Abo T
Eur J Immunol; 2005 Aug; 35(8):2358-66. PubMed ID: 15997467
[TBL] [Abstract][Full Text] [Related]
20. [CD94/NKG2A--a kind of inhibitory receptor belonging to C-type lectin superfamily].
Wang Y; Zhu LP; Zhang W
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Dec; 24(6):653-5. PubMed ID: 12905700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]